Orris

What is resistance hypertension

Reading File
Finding Sources
Searching PubMed

"resistant hypertension"

Searching the Web

resistant hypertension definition American Heart Association guideline diagnosis adherence white coat hypertension

“Resistance hypertension” usually means resistant hypertension.
It is high blood pressure that remains above the treatment target despite taking three different blood-pressure medicines at maximally tolerated doses, typically:
  1. A long-acting calcium-channel blocker
  2. An ACE inhibitor or ARB
  3. A diuretic, often a thiazide-like diuretic
It also includes people whose blood pressure is controlled only by needing four or more medicines. Fuster and Hurst's The Heart, 15th Edition defines it similarly.
Before diagnosing true resistant hypertension, clinicians should rule out pseudo-resistance, such as:
  • Incorrect blood-pressure measurement
  • Missed doses or medication nonadherence
  • “White-coat effect,” where clinic BP is high but home or ambulatory readings are normal
  • Inadequate drug doses or unsuitable combinations
Doctors also evaluate for secondary contributors, such as kidney disease, primary aldosteronism, obstructive sleep apnea, excess salt intake, alcohol, and medications that raise BP, such as NSAIDs. The ESC overview emphasizes confirming home or ambulatory readings and adherence before labeling it resistant.
Resistant hypertension raises the risk of stroke, heart attack, heart failure, and kidney disease, so it needs medical review. Recent systematic reviews include PMID 37890022, but treatment must be individualized rather than changing medicines without a clinician.

Find the latest guidelines for resistant hypertension

Reading File
Reading File
Finding Sources
Searching PubMed

"resistant hypertension" AND guideline

Searching the Web

2024 2025 2026 resistant hypertension guideline society statement PDF guideline

Searching the Web

site:ahajournals.org 2025 AHA ACC Guideline high blood pressure resistant hypertension full guideline

Reading Web Page

https://www.escardio.org/guidelines/clinical-practice-guidel…

Reading Article

PMID: 39653728

Reading Article

PMID: 39589443

Reading Article

PMID: 40419299

The newest major guidance relevant to resistant hypertension is:
  1. 2025 AHA/ACC High Blood Pressure Guideline, United States
    This is the most recent broad US hypertension guideline, published August 2025. It recommends evaluating resistant hypertension for secondary causes, including primary aldosteronism even without low potassium. It supports adding a mineralocorticoid-receptor antagonist, usually spironolactone when suitable, after optimized standard triple therapy. It also permits renal denervation only for carefully selected patients after specialist evaluation and shared decision-making. See the ACC guideline announcement.
  2. British and Irish Hypertension Society position statement, 2025
    This is the newest guideline focused specifically on investigation and management of resistant hypertension: Faconti et al., Journal of Human Hypertension, 2025, PMID 39653728. It emphasizes confirming true resistance, assessing adherence and out-of-office BP, identifying secondary causes, optimizing drug and lifestyle therapy, and referral for specialist review.
  3. 2024 ESC Guidelines for Elevated Blood Pressure and Hypertension, Europe
    Published in August 2024 and corrected in February 2025. These recommend confirming uncontrolled BP with home or ambulatory monitoring, excluding pseudo-resistance, and considering referral to a specialist hypertension center. The official 2024 ESC guideline page provides the full guideline and supporting materials.

Current practical consensus

Across these guidelines, resistant hypertension should be managed by:
  • Confirming accurate BP measurement with home or ambulatory readings.
  • Checking adherence, appropriate doses, lifestyle factors, and BP-raising drugs such as NSAIDs.
  • Ensuring optimized standard therapy, generally an ACE inhibitor or ARB + long-acting calcium-channel blocker + thiazide-like diuretic.
  • Screening for secondary causes, especially primary aldosteronism, kidney disease, renal artery disease, and obstructive sleep apnea.
  • Adding spironolactone if kidney function and potassium permit, with monitoring for hyperkalemia and renal impairment.
  • Considering alternatives if spironolactone is unsuitable or not tolerated.
  • Considering renal denervation only in selected patients after optimal medical treatment and specialist assessment. The ESC describes it as a Class IIb option, meaning it may be considered but is not routine first-line care. See the ESC resistant-hypertension update.
Recent evidence supports ongoing drug optimization and selective interventional options, but does not replace this stepwise approach: Systematic Review, Tier 1, 2024, PMID 37890022.
The two most useful documents to start with are the 2025 AHA/ACC guideline for US practice and the 2025 British and Irish position statement for a detailed resistant-hypertension work-up.

Anti tpo antibodies are 31

Reading File
Finding Sources
Searching PubMed

"thyroid peroxidase antibodies"

Searching the Web

thyroid peroxidase antibody test interpretation reference range TSH official patient guidance

An anti-TPO antibody level of 31 can be normal, borderline, or mildly positive depending on the lab’s reference range and units shown on your report.
Examples of lab cutoffs vary:
  • One NHS laboratory: <25 IU/mL negative, 25-35 borderline, >35 positive. Under this range, 31 is borderline. Example NHS range
  • Another lab uses <34 IU/mL as negative, so 31 would be normal. Example alternative range
Anti-TPO antibodies can indicate autoimmune thyroid inflammation, most commonly Hashimoto thyroiditis, but the number alone does not establish hypothyroidism or mean treatment is needed. The important accompanying tests are:
  • TSH
  • Free T4 and sometimes free T3
  • Symptoms and thyroid examination
  • Pregnancy status or plans for pregnancy
If TSH and free T4 are normal, a mild/borderline anti-TPO level often only means periodic TSH follow-up, rather than thyroid medication. If TSH is raised, it may support autoimmune hypothyroidism as the cause.
If you are pregnant or planning pregnancy, discuss this result with your clinician sooner because TPO positivity can change how closely thyroid function is monitored. Do not use the antibody number alone to start levothyroxine.

Types of hrs

Reading File
Do you mean HRS = hepatorenal syndrome (a kidney complication of advanced liver disease), or another meaning of HRS?
Asking for Preferences

Which HRS do you mean?

This is a shared conversation. Sign in to Orris to start your own chat.